These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 9328845

  • 1. Quantitative immunofluorescence and immunoelectron microscopy of the topoisomerase II alpha associated with nuclear matrices from wild-type and drug-resistant chinese hamster ovary cell lines.
    Valkov NI, Gump JL, Sullivan DM.
    J Cell Biochem; 1997 Oct 01; 67(1):112-30. PubMed ID: 9328845
    [Abstract] [Full Text] [Related]

  • 2. Association of topoisomerase II with the hepatoma cell nuclear matrix: the role of intermolecular disulfide bond formation.
    Kaufmann SH, Shaper JH.
    Exp Cell Res; 1991 Feb 01; 192(2):511-23. PubMed ID: 1846338
    [Abstract] [Full Text] [Related]

  • 3. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
    Sehested M, Wessel I, Jensen LH, Holm B, Oliveri RS, Kenwrick S, Creighton AM, Nitiss JL, Jensen PB.
    Cancer Res; 1998 Apr 01; 58(7):1460-8. PubMed ID: 9537249
    [Abstract] [Full Text] [Related]

  • 4. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
    Sullivan DM, Eskildsen LA, Groom KR, Webb CD, Latham MD, Martin AW, Wellhausen SR, Kroeger PE, Rowe TC.
    Mol Pharmacol; 1993 Feb 01; 43(2):207-16. PubMed ID: 8094226
    [Abstract] [Full Text] [Related]

  • 5. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth.
    Hashimoto S, Chatterjee S, Ranjit GB, Bao C, Ford J, Ganapathi R, Berger SJ, Berger NA.
    Oncol Res; 1995 Feb 01; 7(7-8):407-16. PubMed ID: 8747604
    [Abstract] [Full Text] [Related]

  • 6. Altered subcellular distribution of topoisomerase II alpha in a drug-resistant human small cell lung cancer cell line.
    Feldhoff PW, Mirski SE, Cole SP, Sullivan DM.
    Cancer Res; 1994 Feb 01; 54(3):756-62. PubMed ID: 8306338
    [Abstract] [Full Text] [Related]

  • 7. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
    Harker WG, Slade DL, Parr RL, Feldhoff PW, Sullivan DM, Holguin MH.
    Cancer Res; 1995 Apr 15; 55(8):1707-16. PubMed ID: 7712479
    [Abstract] [Full Text] [Related]

  • 8. Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases IIalpha and beta.
    Turnbull RM, Meczes EL, Perenna Rogers M, Lock RB, Sullivan DM, Finlay GJ, Baguley BC, Austin CA.
    Cancer Chemother Pharmacol; 1999 Apr 15; 44(4):275-82. PubMed ID: 10447574
    [Abstract] [Full Text] [Related]

  • 9. In vivo etoposide-resistant C6 glioma cell line: significance of altered DNA topoisomerase II activity in multi-drug resistance.
    Taki T, Ohnishi T, Arita N, Hiraga S, Hayakawa T.
    J Neurooncol; 1998 Jan 15; 36(1):41-53. PubMed ID: 9525824
    [Abstract] [Full Text] [Related]

  • 10. Increased rate of adenosine triphosphate-dependent etoposide (VP-16) efflux in a murine leukemia cell line overexpressing the multidrug resistance-associated protein (MRP) gene.
    Lorico A, Rappa G, Srimatkandada S, Catapano CV, Fernandes DJ, Germino JF, Sartorelli AC.
    Cancer Res; 1995 Oct 01; 55(19):4352-60. PubMed ID: 7671247
    [Abstract] [Full Text] [Related]

  • 11. Quantitation of DNA topoisomerase IIalpha and beta in human leukaemia cells by immunoblotting.
    Padget K, Pearson AD, Austin CA.
    Leukemia; 2000 Nov 01; 14(11):1997-2005. PubMed ID: 11069037
    [Abstract] [Full Text] [Related]

  • 12. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.
    Kawanami K, Nakamura T, Ono M, Kusano T, Okada K, Kikuchi A, Adachi N, Kohno K, Higashi K, Kuwano M.
    Oncol Res; 1996 Nov 01; 8(5):197-206. PubMed ID: 8884812
    [Abstract] [Full Text] [Related]

  • 13. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
    Asano T, An T, Zwelling LA, Takano H, Fojo AT, Kleinerman ES.
    Oncol Res; 1996 Nov 01; 8(3):101-10. PubMed ID: 8823806
    [Abstract] [Full Text] [Related]

  • 14. [Expression of DNA topoisomerases (I, II alpha, II beta) mRNA in etoposide- and mAMSA-resistant cell lines].
    Matsumoto Y, Takano H, Nagao S, Iglesias A, Fojo T.
    Gan To Kagaku Ryoho; 1997 Dec 01; 24(15):2265-9. PubMed ID: 9422071
    [Abstract] [Full Text] [Related]

  • 15. Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors.
    Oloumi A, MacPhail SH, Johnston PJ, Banáth JP, Olive PL.
    Cancer Res; 2000 Oct 15; 60(20):5747-53. PubMed ID: 11059769
    [Abstract] [Full Text] [Related]

  • 16. Discrete localization of different DNA topoisomerases in HeLa and K562 cell nuclei and subnuclear fractions.
    Zini N, Santi S, Ognibene A, Bavelloni A, Neri LM, Valmori A, Mariani E, Negri C, Astaldi-Ricotti GC, Maraldi NM.
    Exp Cell Res; 1994 Feb 15; 210(2):336-48. PubMed ID: 8299728
    [Abstract] [Full Text] [Related]

  • 17. Combined modalities of resistance in etoposide-resistant human KB cell lines.
    Ferguson PJ, Fisher MH, Stephenson J, Li DH, Zhou BS, Cheng YC.
    Cancer Res; 1988 Nov 01; 48(21):5956-64. PubMed ID: 2844393
    [Abstract] [Full Text] [Related]

  • 18. Induction of resistance to etoposide and adriamycin in a human glioma cell line treated with antisense oligodeoxynucleotide complementary to the messenger ribonucleic acid of deoxyribonucleic acid topoisomerase II alpha.
    Kuriyama M, Tsutsui K, Tsutsui K, Ono Y, Tamiya T, Matsumoto K, Furuta T, Ohmoto T.
    Neurol Med Chir (Tokyo); 1997 Sep 01; 37(9):655-61; discussion 661-2. PubMed ID: 9330528
    [Abstract] [Full Text] [Related]

  • 19. Effects of wild-type p53 expression on the quantity and activity of topoisomerase IIalpha and beta in various human cancer cell lines.
    Hochhauser D, Valkov NI, Gump JL, Wei I, O'Hare C, Hartley J, Fan J, Bertino JR, Banerjee D, Sullivan DM.
    J Cell Biochem; 1999 Nov 01; 75(2):245-57. PubMed ID: 10502297
    [Abstract] [Full Text] [Related]

  • 20. Characterization of human NSCLC cell line with innate etoposide-resistance mediated by cytoplasmic localization of topoisomerase II alpha.
    de Lucio B, Manuel V, Barrera-Rodríguez R.
    Cancer Sci; 2005 Nov 01; 96(11):774-83. PubMed ID: 16271071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.